CD Biosynsis can help customers design ethylene glycol production pathways that rely on renewable resources, based on a synthetic biology platform, and using metabolic and genetic engineering tools. We expect to help our customers achieve efficient production of ethylene glycol in microorganisms through the design and optimization of metabolic pathways for ethylene glycol biosynthesis.
Ethylene glycol is a pass-through chemical, mainly used in the production of polyester fiber, antifreeze, etc. Currently, the industrial production of ethylene glycol is entirely dependent on petrol. The steam cracking of petrol produces ethylene, which is oxidized to produce ethylene oxide. Ethylene oxide is then thermally hydrolyzed to produce ethylene glycol. However, the decreasing availability of petrol and rising market prices make industrial production of ethylene glycol a huge challenge. Finding strategies to develop ethylene glycol based on renewable resources is important to alleviate fossil energy endangerment. Synthetic biology enables the production of ethylene glycol from renewable energy sources.
Figure 1. Biosynthetic routes for ethylene glycol production in recombinant bacteria based on pentose assimilation pathways. (Uranukul B, et al., 2019)
Based on our synthetic biology platform, we are able to help our customers achieve microbiological production of ethylene glycol.
We are able to use metabolic engineering strategies to modify the metabolic pathways of microorganisms to improve the yield of ethylene glycol.
By analyzing the metabolic pathways of microbial ethylene glycol synthesis, we can use genetic engineering tools to regulate the expression of metabolic enzymes to help our customers optimize ethylene glycol synthesis strains.
We are able to help our customers design metabolic pathways for the synthesis of glycols based on certain biomasses.
We are able to regulate or design the metabolic pathway of D-xylose, using genetic engineering tools to overexpress or knock out genes encoding enzymes that play a key role in the pathway of D-xylose to produce ethylene glycol. Ultimately, we can help our customers to realize the production of glycols from xylose as raw material in E. coli or Saccharomyces cerevisiae.
We are able to use metabolic engineering tools to assemble endogenous and exogenous enzymes from microorganisms and design glucose-dependent ethylene glycol production pathways.
CD Biosynsis can develop tailored tools and customized approaches to harness the power of synthetic biology to drive ethylene glycol production and meet the needs of customers in a variety of industries.
As a rapidly growing synthetic biology company, CD Biosynsis is committed to helping our customers meet the growing and evolving demand for bio-based chemical production. All of our deliverables will undergo a rigorous quality testing process to ensure the quality and reliability and can be delivered on time. If you are interested in our services or have any further questions, please do not hesitate to contact us.
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.